Family

Loading Family data...

• 15 United States
• 10 France
• 8 Japan
• 7 China
• 5 Korea
• 2 Other

Patent Owner(s)

• VALEANT PHARMACEUTICALS NORTH AMERICA

International Classification(s)

• A61K:PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOS....

• [Classification Symbol]

• [Patents Count]

Inventor(s)

Inventor Name	Address	# of filed Patents	Total Citations
Brune, Kay	Marloffstein, DE	25	259
Hermann, Robert	Hanau, DE	37	215
Locher, Mathias	Ronneburg, DE	8	56
Szelenyi, Istvan	Schwaig, DE	48	450

Cited Art Landscape

Load Citation

• No Cited Art to Display

Loading Cited Art Landscape...

Patent Citation Ranking

Forward Cite Landscape

Load Citation

• No Forward Cites to Display

Loading Forward Cite Landscape...

Maintenance Fees

Fee	Large entity fee	small entity fee	micro entity fee	due date

Fee	Large entity fee	small entity fee	micro entity fee
Surcharge after expiration - Late payment is unavoidable	$700.00	$350.00	$175.00
Surcharge after expiration - Late payment is unintentional	$1,640.00	$820.00	$410.00

DATE PUBLISHED	PUBLICATION/PATENT NO.	PUBLICATION TYPE
September 21, 2010	US,7799832,B2   US7799832B2	GRANTED PATENT AS SECOND PUBLICATION
April 28, 2005	US,20050090547,A1   US20050090547A1	FIRST PUBLISHED PATENT APPLICATION

Full Text

US Patent No: 7799832

Combinations of retigabine and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains

---

 

Legal Events